NovoCure Limited Ordinary Shares (NVCR) is a publicly traded Healthcare sector company. As of October 28, 2026, NVCR trades at $14.62 with a market cap of $1.68B and a P/E ratio of -10.87. NVCR moved +0.00% today. Year to date, NVCR is +11.43%; over the trailing twelve months it is +7.66%. Its 52-week range spans $9.82 to $21.55. Rallies surfaces NVCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for NVCR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $14.62 |
| Market Cap | $1.68B |
| P/E Ratio | -10.87 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.55 |
| 52-Week Low | $9.82 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $699.19M |
| Net Income | $-148.56M |
| Gross Margin | 76.13% |
NVCR analyst coverage data. Average price target: $0.00.